DURECT Corp (DRRX) - Cash per Single Share

Corporate emblem and logo of DURECT Corp (DRRX)

DURECT Corporation relies on a virtual model, outsourcing synthesis and research to external contractors. The cash position per share on GURU.Markets captures liquidity dynamics, where 0.21 represents the current metric. The process requires precise cold-chain transportation of samples. Meanwhile, management strictly controls the budget while awaiting the publication of validation results for the key asset.

DRRX: durect.com Cash per Single Share 07/04/2022 - 09/27/2025

Analytical breakdowns for DURECT Corporation

- cash position and cash flow details:
Comprehensive company analysis:DURECT Corp - DRRX
Signature product of DURECT

The development of larsucitostat for liver therapy requires significant capital expenditures in clinical trials. The cash per share dynamics for DURECT Corporation (DRRX) reflect the volume of available liquidity allocated to a single common share. This metric measures the business's financial stability and its ability to operate without external borrowing. Analyzing this indicator allows for an assessment of bankruptcy risk or the redundancy of non-working reserves. Investors use this indicator to determine the asset's fundamental safety cushion.